Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism
about
Regulation of adaptive immunity; the role of interleukin-10Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesT-helper cell-mediated proliferation and cytokine responses against recombinant Merkel cell polyomavirus-like particles.Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells.Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation.Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection.Infection, immunoregulation, and cancer.Current status of interleukin-10 and regulatory T-cells in cancerT-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance.The role of cytokines in breast cancer development and progressionNew aspects of natural-killer-cell surveillance and therapy of cancer.IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4(+) T cells and promoting CTL persistence in a murine model of plasmacytomaImmunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer.NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases.Interleukin-10 and the immune response against cancer: a counterpoint.T-cell Expression of IL10 Is Essential for Tumor Immune Surveillance in the Small IntestineVaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination.Interleukin-10 deficiency impairs regulatory T cell-derived neuropilin-1 functions and promotes Th1 and Th17 immunity.Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signalsInterleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model.PEG-rIL-10 treatment decreases FoxP3(+) Tregs despite upregulation of intratumoral IDOThe role of interleukin-10 in the progression of human papillomavirus-associated lung carcinoma.Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin.Dual biological effects of the cytokines interleukin-10 and interferon-γ.The tumor microenvironment: part 1.Pegylated IL-10 induces cancer immunity: the surprising role of IL-10 as a potent inducer of IFN-γ-mediated CD8(+) T cell cytotoxicity.IL-10 stimulatory effects on human NK cells explored by gene profile analysis.Reduced tumorigenesis of EG7 after interleukin-10 gene transfer and enhanced efficacy in combination with intratumorally injection of adenovirus-mediated lymphotactin and the underlying mechanism.Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma.IL-10: Expanding the Immune Oncology Horizon.Interleukin-10 ablation promotes tumor development, growth, and metastasis.Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation.IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: improved control of Trypanosoma cruzi infection.Yoga, Meditation and Mind-Body Health: Increased BDNF, Cortisol Awakening Response, and Altered Inflammatory Marker Expression after a 3-Month Yoga and Meditation Retreat.Clinical significance of IL-2 and IL-10 gene polymorphisms and serum levels in patients with basal-cell carcinoma.Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN.
P2860
Q21131215-2A8B71EC-A653-4C38-9AD6-C679182C1AFDQ26798402-61E8B3C1-B595-49C3-A2F1-58466E69CFA4Q31032531-22597423-3A77-404B-9363-01161D1FF184Q33646189-19B2792D-8F93-4701-A70B-4BA77ED44A67Q33804742-CD92A7EC-C2D4-426D-AC1F-CE2C1D4CA9A1Q33890583-0DCFBAF7-7B97-443B-91A9-58FFBB974097Q33917198-15EF6CFC-4EEF-453C-9C0D-9E54757367E6Q34008436-E00F039B-4048-49A3-9DD6-B7742215220BQ34166653-85FBB523-22EF-4B3D-B107-2AABD9AE9E91Q34374026-CBBF7AA1-61E7-42DB-A796-EF5E2E88A50CQ34452013-FF10EED9-B86C-49A1-AE9A-E70D1517F2C6Q34920381-645E8829-3EF5-4F6C-B8A7-B4F1CC8FF2ADQ34988265-E8DB9399-E7DB-4872-B7D9-257BCD8864D6Q35134651-D527F8A0-37A9-49A3-92DD-163C636B2BC6Q35799158-37BF8D28-B5BD-45CB-A85C-CF2E6837624CQ35861249-9181FB18-0FF3-45A1-9EBF-A7C494B60523Q35956535-C6E13838-051F-4A46-A21A-42243F5F65EAQ36276594-FB898509-A31A-45A8-903C-D29D90349120Q36567445-A05E8955-6AED-47DC-913D-2C8B0A30E93EQ36710936-6B7BE70E-9E85-4C85-B32D-FC0FDBF51684Q36796532-3016B2B1-7712-406A-BFC0-B39C6B5A38C3Q36907152-2D266D93-3817-4FF9-B99E-2FA4BCEA7177Q36925312-9DFD94B6-7954-4DDF-8477-A094093518E7Q37222162-C78C2158-A53E-4550-BCEC-838153911F54Q37302691-18A554A2-A5E8-41CD-BEF9-BA6FA3EF96CBQ37346143-7A6A51BC-8942-420E-B0B6-3130C36F0E38Q37379766-2D192D90-EC0D-46EE-AB9B-093498FFB5C5Q37932437-AE97939C-154D-45D9-8566-8A37DEDB5362Q37952794-B47E8240-40A4-4F00-8F56-2B438519B396Q38105994-644F6FD8-32F1-4F6E-958B-7D53E0C9493FQ38333675-48A60511-2AC4-4C2E-9BE1-ADE6218FEEEDQ39607063-8A93C312-95D9-46F9-AD63-9E016383F650Q39647944-E2F6F39E-F6F3-4DC3-9E63-DBBBAA1542F8Q40217856-9CDC120F-3200-4A29-A38C-09FBCACFB9DEQ40507111-668FEDC3-F6B0-4701-887E-AE0FC06863B2Q40747726-1E9774B3-F025-4D69-A96D-FD98A16E33BDQ41017961-4C3CF488-2B2F-4391-8405-B5298E86AEA9Q41050177-781B8B45-2F50-4B5E-89E0-838BA084A38EQ41095136-EEF9FF8B-F397-4969-BBE1-175A89597FC5Q41590198-70CA692D-0F68-493E-A753-D009BAE796CD
P2860
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism
@ast
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism
@en
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism
@nl
type
label
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism
@ast
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism
@en
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism
@nl
prefLabel
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism
@ast
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism
@en
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism
@nl
P2093
P2860
P356
P1476
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism
@en
P2093
P2860
P304
P356
10.1084/JEM.184.2.579
P407
P577
1996-08-01T00:00:00Z